Endform, a developer tooling company focused on accelerating Playwright end-to-end testing, has raised €1.5 million in pre-seed funding to further build its parallel test execution platform. The round was led by Alliance VC, with participation from First Fellow, Greens, and Antler, alongside angel investors from Netlify, Wolt, Voi, and CTO Roundtable.
The company is building infrastructure that enables Playwright test suites to run massively in parallel, with each test executed on its own isolated machine. This architecture allows entire test suites to complete in the time it takes to run the slowest individual test, regardless of whether there are 10 tests or 1,000.
Endform is designed as a drop-in replacement for existing Playwright setups, requiring no changes to tests, configuration, or infrastructure. Developers can switch to the platform by replacing a single CLI command.
The platform has already been adopted by production teams. One example includes Lovable, which increased its test count by 10x while reducing runtime by more than 80%. The company now runs over 400,000 Playwright tests per week using Endform.
Endform is currently operated by a two-person team, which has built the Rust-based CLI, execution infrastructure, and analytics platform. The newly raised capital will be used to expand the engineering team and hire initial go-to-market roles.
Looking ahead, the company plans to enhance its analytics capabilities to help developers identify flaky and failing tests earlier, along with improving debugging tools. The broader goal is to enable developers to scale their testing without being constrained by infrastructure limitations.
